Peptide Vaccination Against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients

Peptide Vaccination Against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients

Introduction: Cytomegalovirus (CMV) reactivation occurs in seronegative patients after solid organ transplantation (SOT) particularly from seropositive donors and can be lethal. Generation of CMV-specific T cells helps to prevent CMV reactivation. Therefore, we initiated a clinical phase I CMVpp65 p...

Full description

Bibliographic Details
Main Authors: Claudia Sommerer, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier, Michael Schmitt
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Vaccines
Subjects:
cytomegalovirus (CMV)
CMV reactivation
phosphoprotein 65 (pp65) peptide vaccination
specific T cells
renal transplantation
Online Access:https://www.mdpi.com/2076-393X/9/2/133

Internet

https://www.mdpi.com/2076-393X/9/2/133

Similar Items